- Home
- PTGX vs FIZZ Comparison
PTGX vs FIZZ Comparison
Compare PTGX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- FIZZ
- Stock Information
- Founded
- PTGX 2006
- FIZZ 1985
- Country
- PTGX United States
- FIZZ United States
- Employees
- PTGX N/A
- FIZZ N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- FIZZ Beverages (Production/Distribution)
- Sector
- PTGX Health Care
- FIZZ Consumer Staples
- Exchange
- PTGX Nasdaq
- FIZZ Nasdaq
- Market Cap
- PTGX 5.0B
- FIZZ 3.1B
- IPO Year
- PTGX 2016
- FIZZ 1991
- Fundamental
- Price
- PTGX $84.49
- FIZZ $33.49
- Analyst Decision
- PTGX Strong Buy
- FIZZ Strong Sell
- Analyst Count
- PTGX 9
- FIZZ 1
- Target Price
- PTGX $86.44
- FIZZ $39.00
- AVG Volume (30 Days)
- PTGX 887.0K
- FIZZ 347.5K
- Earning Date
- PTGX 11-06-2025
- FIZZ 12-04-2025
- Dividend Yield
- PTGX N/A
- FIZZ N/A
- EPS Growth
- PTGX N/A
- FIZZ 0.66
- EPS
- PTGX 0.72
- FIZZ 1.98
- Revenue
- PTGX $209,217,000.00
- FIZZ $1,202,396,000.00
- Revenue This Year
- PTGX N/A
- FIZZ $2.80
- Revenue Next Year
- PTGX $140.23
- FIZZ $2.19
- P/E Ratio
- PTGX $117.62
- FIZZ $16.44
- Revenue Growth
- PTGX N/A
- FIZZ 0.46
- 52 Week Low
- PTGX $33.31
- FIZZ $32.21
- 52 Week High
- PTGX $93.25
- FIZZ $50.51
- Technical
- Relative Strength Index (RSI)
- PTGX 64.48
- FIZZ 44.40
- Support Level
- PTGX $82.06
- FIZZ $32.32
- Resistance Level
- PTGX $86.90
- FIZZ $33.83
- Average True Range (ATR)
- PTGX 3.11
- FIZZ 0.93
- MACD
- PTGX 0.14
- FIZZ 0.16
- Stochastic Oscillator
- PTGX 77.23
- FIZZ 60.91
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).